Market revenue in 2024 | USD 25.1 million |
Market revenue in 2030 | USD 45.2 million |
Growth rate | 10.5% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 70.52% in 2024. Horizon Databook has segmented the Argentina deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Moreover, rising incidence of Alzheimer’s disease and dementia in Argentina owing to increase in geriatric population is a key factor contributing to the growth of the market. According to the statistics published by the Alzheimer's Association Argentina.
In 2016, Alzheimer's disease was the fifth leading cause of death, affecting around 300,000 people in the country. Moreover, rising penetration of health insurance coupled with technological advancements is likely to drive growth of the market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account